FDA allows sale of Ranbaxy tablets in the US

Monday, 13 August 2007, 07:00 Hrs
Printer Print Email Email
Mumbai: Leading drug maker Ranbaxy's U.S subsidiary Ohm Laboratories Monday said that it has received the US Food and Drug Administration's (FDA) permission to market Metformin Hydrochloride tablets that are used for treating diabetes.

The Florida-based Ranbaxy Pharmaceuticals, which is a wholly-owned subsidy of Ranbaxy Laboratories, informed the Bombay Stock Exchange (BSE) Monday that it was given the approval to market Metformin Hydrochloride tablets in multiple strengths of 500 mg, 850 mg and 1,000 mg in the US market through Ohm Laboratories.

Ohm Laboratories was set up jointly by Ipca Laboratories and Ranbaxy Pharmaceuticals. Ipca Laboratories, which is setting up a new manufacturing unit at Indore, would manufacture Metformin Hydrochloride in India, the information given to the BSE said.

According to industry data, the annual US sales of the drug stand at $379 million.
Source: IANS
SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..